Literature DB >> 24427068

2,6-Di-fluoro-N-(prop-2-yn-yl)benzamide.

Zahid Hussain1, Ejaz Hussain1, Hina Siddiqui1, M Iqbal Choudhary2, Sammer Yousuf1.   

Abstract

In the mol-ecule of the title di-fluoro-benzamide derivative, C10H7F2NO, the angle formed by the least-squares mean line through the prop-2-ynyl group [maximum deviation = 0.011 (3) Å] and the normal to the benzene ring is 59.03 (7)°. In the crystal, mol-ecules are linked via N-H⋯O and C-H⋯F hydrogen bonds into layers parallel to the ac plane.

Entities:  

Year:  2013        PMID: 24427068      PMCID: PMC3884469          DOI: 10.1107/S1600536813021120

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of di­fluoro­benzamide derivatives, see: Chang et al. (2002 ▶); Kees et al. (1989 ▶); Ragavan et al. (2010 ▶); Carmellino et al. (1994 ▶); Rauko et al. (2001 ▶). For the crystal structure of a related compound, see: Fun et al. (2010 ▶).

Experimental

Crystal data

C10H7F2NO M = 195.17 Monoclinic, a = 5.0479 (8) Å b = 19.738 (3) Å c = 9.2428 (15) Å β = 91.432 (4)° V = 920.6 (3) Å3 Z = 4 Mo Kα radiation μ = 0.12 mm−1 T = 273 K 0.38 × 0.17 × 0.10 mm

Data collection

Bruker SMART APEX CCD diffractometer 5388 measured reflections 1669 independent reflections 1283 reflections with I > 2σ(I) R int = 0.022

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.099 S = 1.03 1669 reflections 135 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.13 e Å−3 Δρmin = −0.15 e Å−3 Data collection: SMART (Bruker, 2000 ▶); cell refinement: SAINT (Bruker, 2000 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536813021120/rz5082sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813021120/rz5082Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S1600536813021120/rz5082Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H7F2NOF(000) = 400
Mr = 195.17Dx = 1.408 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 1280 reflections
a = 5.0479 (8) Åθ = 2.4–22.9°
b = 19.738 (3) ŵ = 0.12 mm1
c = 9.2428 (15) ÅT = 273 K
β = 91.432 (4)°Block, colourless
V = 920.6 (3) Å30.38 × 0.17 × 0.10 mm
Z = 4
Bruker SMART APEX CCD diffractometer1283 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.022
Graphite monochromatorθmax = 25.5°, θmin = 2.1°
phi and ω scansh = −6→6
5388 measured reflectionsk = −23→22
1669 independent reflectionsl = −10→11
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.099H atoms treated by a mixture of independent and constrained refinement
S = 1.03w = 1/[σ2(Fo2) + (0.0397P)2 + 0.172P] where P = (Fo2 + 2Fc2)/3
1669 reflections(Δ/σ)max < 0.001
135 parametersΔρmax = 0.13 e Å3
0 restraintsΔρmin = −0.15 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
F10.4706 (2)0.66642 (6)0.01184 (13)0.0784 (4)
F21.1590 (2)0.68247 (6)−0.31627 (13)0.0808 (4)
O11.0617 (2)0.56728 (6)−0.15774 (16)0.0689 (4)
N10.6219 (3)0.55850 (7)−0.17077 (17)0.0520 (4)
C10.6337 (3)0.70378 (9)−0.06950 (19)0.0533 (5)
C20.6133 (4)0.77291 (10)−0.0635 (2)0.0670 (6)
H2A0.48840.7934−0.00550.080*
C30.7807 (4)0.81150 (10)−0.1445 (2)0.0690 (6)
H3A0.76850.8585−0.14190.083*
C40.9655 (4)0.78117 (10)−0.2290 (2)0.0664 (5)
H4A1.08020.8071−0.28350.080*
C50.9778 (3)0.71209 (9)−0.2314 (2)0.0546 (5)
C60.8147 (3)0.66992 (8)−0.15372 (17)0.0453 (4)
C70.8430 (3)0.59431 (9)−0.16021 (17)0.0475 (4)
C80.6276 (4)0.48497 (9)−0.1809 (2)0.0607 (5)
H8A0.45350.4673−0.15990.073*
H8B0.75190.4674−0.10850.073*
C90.7041 (4)0.46128 (9)−0.3233 (2)0.0621 (5)
C100.7642 (5)0.44382 (12)−0.4380 (3)0.0880 (7)
H10.475 (4)0.5775 (9)−0.1715 (19)0.061 (6)*
H20.817 (5)0.4327 (13)−0.524 (3)0.120 (10)*
U11U22U33U12U13U23
F10.0691 (7)0.0792 (8)0.0889 (9)−0.0091 (6)0.0395 (6)−0.0161 (6)
F20.0727 (7)0.0810 (8)0.0907 (9)−0.0041 (6)0.0418 (7)−0.0052 (6)
O10.0315 (6)0.0655 (8)0.1096 (11)0.0057 (5)0.0013 (6)−0.0028 (7)
N10.0316 (7)0.0521 (9)0.0726 (11)0.0022 (6)0.0071 (7)−0.0047 (7)
C10.0412 (9)0.0628 (11)0.0559 (11)−0.0019 (8)0.0054 (8)−0.0104 (9)
C20.0543 (10)0.0674 (13)0.0794 (14)0.0088 (9)0.0033 (10)−0.0230 (10)
C30.0648 (12)0.0532 (11)0.0885 (16)0.0037 (9)−0.0073 (11)−0.0048 (10)
C40.0604 (11)0.0634 (12)0.0753 (14)−0.0065 (9)0.0039 (10)0.0069 (10)
C50.0432 (9)0.0629 (11)0.0579 (11)−0.0003 (8)0.0070 (8)−0.0048 (9)
C60.0320 (8)0.0553 (10)0.0484 (10)0.0000 (7)−0.0021 (7)−0.0053 (8)
C70.0328 (8)0.0571 (10)0.0527 (10)0.0014 (7)0.0052 (7)−0.0023 (8)
C80.0503 (10)0.0529 (11)0.0794 (14)−0.0025 (8)0.0094 (9)0.0042 (9)
C90.0579 (11)0.0451 (10)0.0835 (16)0.0055 (8)0.0048 (11)−0.0031 (10)
C100.1032 (19)0.0689 (15)0.092 (2)0.0121 (12)0.0132 (16)−0.0128 (14)
F1—C11.3482 (19)C3—H3A0.9300
F2—C51.3530 (18)C4—C51.365 (3)
O1—C71.2256 (17)C4—H4A0.9300
N1—C71.323 (2)C5—C61.384 (2)
N1—C81.455 (2)C6—C71.501 (2)
N1—H10.830 (19)C8—C91.458 (3)
C1—C21.370 (3)C8—H8A0.9700
C1—C61.387 (2)C8—H8B0.9700
C2—C31.374 (3)C9—C101.162 (3)
C2—H2A0.9300C10—H20.87 (3)
C3—C41.369 (3)
C7—N1—C8121.31 (15)F2—C5—C6117.42 (16)
C7—N1—H1120.7 (13)C4—C5—C6124.38 (16)
C8—N1—H1118.0 (13)C5—C6—C1114.22 (16)
F1—C1—C2118.34 (15)C5—C6—C7121.27 (14)
F1—C1—C6118.01 (16)C1—C6—C7124.49 (15)
C2—C1—C6123.65 (17)O1—C7—N1121.78 (16)
C1—C2—C3118.85 (17)O1—C7—C6121.24 (14)
C1—C2—H2A120.6N1—C7—C6116.97 (13)
C3—C2—H2A120.6N1—C8—C9112.60 (15)
C4—C3—C2120.37 (18)N1—C8—H8A109.1
C4—C3—H3A119.8C9—C8—H8A109.1
C2—C3—H3A119.8N1—C8—H8B109.1
C5—C4—C3118.53 (18)C9—C8—H8B109.1
C5—C4—H4A120.7H8A—C8—H8B107.8
C3—C4—H4A120.7C10—C9—C8178.5 (2)
F2—C5—C4118.19 (16)C9—C10—H2176.4 (19)
F1—C1—C2—C3179.19 (17)C2—C1—C6—C50.6 (3)
C6—C1—C2—C3−0.2 (3)F1—C1—C6—C7−0.3 (2)
C1—C2—C3—C4−0.4 (3)C2—C1—C6—C7179.05 (18)
C2—C3—C4—C50.4 (3)C8—N1—C7—O1−0.4 (3)
C3—C4—C5—F2179.33 (17)C8—N1—C7—C6178.68 (15)
C3—C4—C5—C60.1 (3)C5—C6—C7—O141.8 (2)
F2—C5—C6—C1−179.83 (15)C1—C6—C7—O1−136.53 (18)
C4—C5—C6—C1−0.6 (3)C5—C6—C7—N1−137.26 (17)
F2—C5—C6—C71.7 (2)C1—C6—C7—N144.4 (2)
C4—C5—C6—C7−179.07 (18)C7—N1—C8—C9−75.0 (2)
F1—C1—C6—C5−178.74 (15)
D—H···AD—HH···AD···AD—H···A
N1—H1···O1i0.83 (2)2.10 (2)2.8387 (19)147.4 (17)
C2—H2A···F2ii0.932.493.394 (2)164
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N1—H1⋯O1i 0.83 (2)2.10 (2)2.8387 (19)147.4 (17)
C2—H2A⋯F2ii 0.932.493.394 (2)164

Symmetry codes: (i) ; (ii) .

  5 in total

1.  Perfluoro-N-[4-(1H-tetrazol-5-ylmethyl)phenyl]alkanamides. A new class of oral antidiabetic agents.

Authors:  K L Kees; R S Cheeseman; D H Prozialeck; K E Steiner
Journal:  J Med Chem       Date:  1989-01       Impact factor: 7.446

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Antitumor activity of benzamide riboside and its combination with cisplatin and staurosporine.

Authors:  P Rauko; L Novotny; I Dovinova; L Hunakova; T Szekeres; H N Jayaram
Journal:  Eur J Pharm Sci       Date:  2001-02       Impact factor: 4.384

4.  Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles.

Authors:  R Venkat Ragavan; V Vijayakumar; N Suchetha Kumari
Journal:  Eur J Med Chem       Date:  2009-12-28       Impact factor: 6.514

5.  N-(4-Cyano-phen-yl)-2,6-difluoro-benzamide.

Authors:  Hoong-Kun Fun; Jia Hao Goh; Janardhana Gowda; A M Khader; B Kalluraya
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.